Amylyx Pharmaceuticals

Amylyx Pharmaceuticals is a neuroscience-focused biopharmaceutical company dedicated to developing innovative treatments for neurodegenerative diseases like ALS, PSP, and Wolfram syndrome. Our flagship product, RELYVRIO (ALBRIOZA in Canada), represents a significant advancement in ALS treatment, and we're actively pursuing further advancements through our pipeline. We're making a tangible impact on patients' lives by addressing the root causes of these debilitating conditions. Our approach is driven by scientific rigor and a commitment to collaborative innovation. Amylyx leverages a robust technology stack that includes tools like Google Tag Manager, Google Analytics, and a Content Delivery Network (CDN) to ensure efficient data management and seamless product delivery. We foster a dynamic and collaborative engineering culture, combining cutting-edge technologies with a focus on data-driven decision-making. Our values of Audacious, Curious, Authentic, Engaging and Accountable guide our work and inform our interactions – leading to a supportive and innovative environment. We offer a variety of roles including remote-friendly options, providing the flexibility to contribute meaningfully to our mission from diverse locations. Amylyx is a rapidly growing company, having recently undergone a successful IPO, showing our commitment to continuing to deliver impactful treatments for patients. We encourage collaborative, unconventionally-thinking individuals to join our team and help us make a difference in the fight against neurodegenerative diseases. Our company is committed to creating a positive and inclusive workplace for everyone. We are an equal opportunity employer and value diversity at our company. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.